OGOREK ANTHONY JOSEPH /NY/ /ADV - SORRENTO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
OGOREK ANTHONY JOSEPH /NY/ /ADV ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$0
-100.0%
3,6000.0%0.00%
Q2 2023$10.0%3,6000.0%0.00%
Q1 2023$1
-66.7%
3,6000.0%0.00%
-100.0%
Q4 2022$3
-99.9%
3,6000.0%0.00%
-50.0%
Q3 2022$5,000
-28.6%
3,6000.0%0.00%
-33.3%
Q2 2022$7,000
-12.5%
3,6000.0%0.00%0.0%
Q1 2022$8,000
-50.0%
3,6000.0%0.00%
-57.1%
Q4 2021$16,000
-40.7%
3,6000.0%0.01%
-41.7%
Q3 2021$27,000
-20.6%
3,6000.0%0.01%
-20.0%
Q2 2021$34,000
+17.2%
3,6000.0%0.02%
+7.1%
Q1 2021$29,000
+20.8%
3,6000.0%0.01%
+7.7%
Q4 2020$24,0003,6000.01%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders